Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Events
  4. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Life Sciences
  • Healthcare
Life Sciences

Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.

Learn More
Life Sciences
Healthcare

Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.

Learn More
Healthcare
MAIN/Insights
Insights/
U.S. PROGRESS POINT

A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.

LEARN MORE
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS

PODCASTS

"Discover the future through our enlightening podcasts available in the United States.

EXPLORE PODCASTS

FACT SHEET

"IQVIA AI Medical Record Review

LEARN MORE

BLOG

"Decoding DSCSA: Ensuring Compliance in the Pharmaceutical Supply Chain

READ MORE
MAIN/Events
Events/
ON-DEMAND WEBINARS

Visit our library of on-demand webinars.

WATCH ON-DEMAND WEBINARS
UPCOMING EVENTS & WEBINARS

View our upcoming events and webinars.

DISCOVER EVENTS & WEBINARS

EVENT

"26th Controlled Substances and State Regulatory Conference

REGISTER NOW
MAIN/Contact Us
Contact Us/
Market Insights

Market Insights

From U.S. Progress Point: Market trends and dynamics impacting your U.S. business today and strategic plans for tomorrow
Subscribers' Circle
Locations United States U.S. Progress Point Market Insights
Insight brief
The Cyberattack of 2024: A Moment of Reckoning for the Stability of Healthcare Data
This paper explores the complexities of healthcare data processing, the impact on medical and prescription claims, and strategies for maintaining business continuity during disruptions.
BUILD RESILIENCE

Latest On Launch

Launch Excellence, U.S. Edition: The Rewrite of the Business Launch

Today, a successful launch is no longer defined by just dollars — it’s defined by the number of patients reached, acquired, and retained. To reflect this new reality, we’ve refined our take on the modern launch, and carefully considered what needs to change to achieve commercial success in a pressurized environment.

In this paper, IQVIA experts discuss the clear need for a rewrite of the modern launch playbook.

LAUNCH INTO THE FUTURE
WEBINAR
U.S. Launch Excellence: Part III – Growth
Successful launches have established a clear trajectory during the first two phases, roughly corresponding to the first two years on the market. Now that brand leaders have identified how to best acquire patients and optimize resources, they need to adopt a growth mindset.
WATCH ON-DEMAND

Market Access Insights

Navigating the market access and financial landscape

The path to the market access summit can be steep, winding, and, at times, unclear. From navigating the complexities of payer requirements to disruption from the Inflation Reduction Act of 2022, you require the best equipment, knowledge, and insights to climb with confidence and reach the apex of your products’ potential.

FROM THE U.S. PROGRESS POINT EDITORIAL BOARD
Their Finest Hour: Medical Affairs in a Disrupted World
Our perspective on the new Medical Affairs collaboration model, the importance of redefining value and the demand for alignment between pharma, HCPs, and healthcare systems to improve performance and achieve optimal health outcomes.
MISSION-CRITICAL MEDICAL AFFAIRS

INSIGHT BRIEF

Ten MedTech Trends to Watch in 2024

2024 will be a year of diverse challenges for MedTech companies, some of which presage potentially significant changes before the decade is over. This insight brief covers ten of the top trends IQVIA MedTech experts see on the horizon and the implications for the MedTech industry.

Explore 2024 Trends

PRIVACY ANALYTICS

Privacy Strategy: Accelerating the Journey to Big Data Outcomes

Patient data is an invaluable resource in every life sciences organization’s quest to develop novel and innovative treatments. Yet many organizations still take a reactive approach — evaluating privacy concerns as projects arise and often relying on highly manual business processes to do so.

Read our latest insight brief to learn three steps for building a privacy strategy that addresses your existing data needs while creating a foundation for managing future expansions — with greater speed and cost efficiency.

Get Serious About Privacy

Transitional Assistance Programs in the GLP-1 Market

Transitional assistance is now part of the standard launch brand toolkit, but little research has been conducted on the impact that these programs have on long-term brand success. Using a selection of GLP-1s as an entry point, this blog measures the role and impact of manufacturer-sponsored patient support at launch and beyond.

THREE LAUNCH STORIES
ON THE HORIZON
Top Trends to Watch in 2024
As always, the turn of the year brings a sense of possibility – and it feels especially heightened for 2024. Looking ahead, we’ve curated a thought-provoking collection of ideas, predictions, and trends that we anticipate will have an outsized impact over the coming year.

Read the full piece to explore our complete list of top trends for 2024 – areas of growth and evolution – that will impact the pharma industry and healthcare.
What's ahead in 2024

A REMARKABLE LAUNCH

Mounjaro: A New Era of Preventive Care and Consumer Health

With less than a year on the market, Mounjaro is already performing like few other medications we have seen in the past decade. Unpacking this remarkable launch makes it clear that Mounjaro isn’t just an outlier; it is a torchbearer for an entirely new category of medicine and demonstrates the shifting (or blurring) line between consumer and medical avenues of care.

A REMARKABLE LAUNCH
One More Time: Preparing for Another Round of Drug Pricing Negotiation

As part of the Inflation Reduction Act (IRA), 10 drugs were selected for negotiation in September 2023 and will be subject to Maximum Fair Price (MFP) in 2026. As the complex process of price negotiation unfolds, stakeholders will need to leverage modeling and scenario planning to determine the impact this new policy may have – directly or indirectly.

How will it play out?
See the whole board

The Inflation Reduction Act of 2022 is poised to be a watershed event for the U.S. healthcare system, setting up a complex chess game for pharmaceutical manufacturers.

In this brief, a team of IQVIA industry experts – from policy and market access to brand strategy and financial planning – establish the contours of the conversation and elucidate both short-term impact and long-term implication.

Consider your opening gambit

An Alzheimer’s perspective

How Will We Remember This Moment?

For the first time, patients living with Alzheimer’s disease and their families have options. Yet, the recent approvals and market performance of disease-modifying treatments demonstrate a glaring truth: the healthcare system is unprepared to deliver the hope that these new treatments promise. What can the healthcare ecosystem do to be ready for their impact?

In this paper, we tackle what is needed to reach as many patients as possible, diving deep into the alignment that must exist in and between five key areas: advocacy, approval, adoption, access, and adherence.

BRACE FOR IMPACT

From the IQVIA Institute for Human Data Science

Institute Report
Accelerating Health Equity: Challenges and Opportunities

Institute Report
Global Oncology Trends 2024: Outlook to 2028

INSTITUTE REPORT
The Use of Medicines in the U.S. 2024: Usage and Spending Trends and Outlook to 2028

INSTITUTE REPORT
U.S.-India Medicine Partnership: India's Contribution to the U.S. Healthcare System

Institute Report
Trends in Adult Vaccination in the U.S.

WEBINAR
The Global Use of Medicines 2024

Institute Report
Trends in Global Adult Vaccination: A View from Five Global Cities

Institute Report
The Use of Medicines in the U.S. 2023

Prev
Next
U.S. Progress Point Subscribers' Circle: First-looks, exclusive content, and more.
Subscribe

INSIGHTS LIBRARY

Looking For More?

We hope you’re enjoying U.S. Progress Point, a curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the U.S. healthcare market.

For additional Thought Leadership content from experts throughout IQVIA, including webinars, blogs, white papers, and case studies, please visit our Library of Insights.

EXPLORE INSIGHTS LIBRARY
Contact Us